The average one-year price target for Adc Therapeutics (NYSE:ADCT) has been revised to 8.77 / share. This is an increase of 9.79% from the prior estimate of 7.99 dated October 4, 2023. The price ...

View ADC Therapeutics Ltd ADCT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Stephens analyst has initiated coverage on ADC Therapeutics SA (NYSE:ADCT), a commercial-stage oncology-focused biotechnology company developing antibody-drug conjugates (ADCs) for patients with ...

ADC Therapeutics (ADCT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.

Swiss biotech ADC Therapeutics has abandoned one of its midpipeline candidates for HER2-positive cancers because of toxicity issues in a phase 1 trial in solid tumors. The company has stressed however ...

ADC Therapeutics has raised $200 million (€170 million), bringing its total haul up to $455 million. The antibody-drug conjugate (ADC) specialist will use the money to take its two lead hematological ...